News & Discoveries

January 01, 2020

Tau PET Brain Imaging Could Launch Precision Medicine Era for Alzheimer’s DiseaseBrain imaging of pathological tau-protein reliably predicts the location of future brain atrophy in Alzheimer’s patients a year or more in advance.

December 17, 2019

Fenfluramine Reduces Seizures, Is Safe for Patients with Dravet, Study Shows A drug that once helped obese adults lose weight, but was withdrawn from the market due to heart risks, may be safe and effective for children with a life-threatening seizure disorder called Dravet syndrome.

December 16, 2019

From international awards for high-caliber research to groundswell movements for social change, this past year was an eventful one for the UCSF community.

December 16, 2019

Browse the stories that most engaged our readers in 2019.

December 13, 2019

New Clinic Follows $18M Gift from Bay Area Entrepreneurs Jan Shrem, Maria Manetti ShremPatients with ambiguous neurological symptoms, but no diagnosis, frequently go from specialist-to-specialist over a protracted period of time. The new clinic’s goal is to fast-forward the time lapses between appointments by enabling pre-diagnostic screening and expert consultations to take place in a single visit.

November 20, 2019

Neuroscientists discovered how the listening brain scans speech to break it down into syllables. The findings provide for the first time a neural basis for the fundamental atoms of language and insights into our perception of the rhythmic poetry of speech.

November 14, 2019

Using standard animal model of Down syndrome, scientists were able to correct the learning and memory deficits associated with the condition with drugs that target the body’s response to cellular stresses.

November 14, 2019

We commonly think a full stomach is what tells us to stop eating, but it may be that a stretched intestine plays an even bigger role in making us feel sated.

November 12, 2019

$106 Million Initiative Will Accelerate Neuroscience Research by Embracing Artificial Intelligence, Engineering, Data Science, Other ‘Nontraditional’ FieldsWith a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.

November 11, 2019

Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.